Showing 18,041 - 18,060 results of 105,386 for search '(( 5 ((mean decrease) OR (a decrease)) ) OR ( e ((fold decrease) OR (point decrease)) ))', query time: 1.17s Refine Results
  1. 18041
  2. 18042

    Electrochemical, Computational, and Photophysical Characterization of New Luminescent Dirhenium–Pyridazine Complexes Containing Bridging OR or SR Anions by Alessio Raimondi (2108038)

    Published 2012
    “…A series of [Re<sub>2</sub>(μ-ER)<sub>2</sub>(CO)<sub>6</sub>(μ-pydz)] complexes have been synthesized (E = S, R = C<sub>6</sub>H<sub>5</sub>, <b>2</b>; E = O, R = C<sub>6</sub>F<sub>5</sub>, <b>3</b>; C<sub>6</sub>H<sub>5</sub>, <b>4</b>; CH<sub>3</sub>, and <b>5</b>; H, <b>6</b>), starting either from [Re­(CO)<sub>5</sub>O<sub>3</sub>SCF<sub>3</sub>] (for <b>2</b> and <b>4</b>), [Re<sub>2</sub>(μ-OR)<sub>3</sub>(CO)<sub>6</sub>]<sup>−</sup> (for <b>3</b> and <b>5</b>), or [Re<sub>4</sub>(μ<sub>3</sub>-OH)<sub>4</sub>(CO)<sub>12</sub>] (for <b>6</b>). …”
  3. 18043

    Electrochemical, Computational, and Photophysical Characterization of New Luminescent Dirhenium–Pyridazine Complexes Containing Bridging OR or SR Anions by Alessio Raimondi (2108038)

    Published 2012
    “…A series of [Re<sub>2</sub>(μ-ER)<sub>2</sub>(CO)<sub>6</sub>(μ-pydz)] complexes have been synthesized (E = S, R = C<sub>6</sub>H<sub>5</sub>, <b>2</b>; E = O, R = C<sub>6</sub>F<sub>5</sub>, <b>3</b>; C<sub>6</sub>H<sub>5</sub>, <b>4</b>; CH<sub>3</sub>, and <b>5</b>; H, <b>6</b>), starting either from [Re­(CO)<sub>5</sub>O<sub>3</sub>SCF<sub>3</sub>] (for <b>2</b> and <b>4</b>), [Re<sub>2</sub>(μ-OR)<sub>3</sub>(CO)<sub>6</sub>]<sup>−</sup> (for <b>3</b> and <b>5</b>), or [Re<sub>4</sub>(μ<sub>3</sub>-OH)<sub>4</sub>(CO)<sub>12</sub>] (for <b>6</b>). …”
  4. 18044
  5. 18045

    Merkel Cell Polyomavirus Small T Antigen Promotes Pro-Glycolytic Metabolic Perturbations Required for Transformation by Christian Berrios (127454)

    Published 2016
    “…While MYC was required for MCT1 induction, MCPyV-induced MCT1 levels decreased following knockdown of the NF-κB subunit RelA, supporting a synergistic activity between MCPyV and MYC in regulating MCT1 levels. …”
  6. 18046
  7. 18047
  8. 18048
  9. 18049
  10. 18050

    A Family of Binuclear Dysprosium(III) Radical Compounds with Magnetic Relaxation in ON and OFF States by Tian Han (1674109)

    Published 2012
    “…The adduct ([Dy­(hfac)<sub>3</sub>(PyNONIT)]<sub>2</sub>[Dy<sub>0.5</sub>(hfac)<sub>1.5</sub>(H<sub>2</sub>O)]<sub>2</sub>) (<b>3</b>) consists of two items, the dimer [Dy­(hfac)<sub>3</sub>(PyNONIT)]<sub>2</sub> and the monomer [Dy­(hfac)<sub>3</sub>(H<sub>2</sub>O)<sub>2</sub>], where the symmetry of Dy<sup>III</sup> ion in Dy<sub>2</sub>O<sub>2</sub> decreases to <i>D</i><sub>2<i>d</i></sub>, showing slow relaxation of the magnetization at lower temperature. …”
  11. 18051

    Physiological Markers of Arousal Change with Psychological Treatment for Insomnia: A Preliminary Investigation by Christopher B. Miller (838716)

    Published 2015
    “…</p><p>Results</p><p>Eight (73%) patients out of 11 consented completed therapy and showed a decrease in insomnia severity pre-to-post treatment (mean (SD): 18.1 (2.8) versus 8.4 (4.8); <i>p</i> = .001). …”
  12. 18052
  13. 18053
  14. 18054
  15. 18055
  16. 18056
  17. 18057

    The data of meta-analysis. by Fei Lin (156666)

    Published 2023
    “…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
  18. 18058

    Quality assessment for risk of bias for studies. by Fei Lin (156666)

    Published 2023
    “…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
  19. 18059

    Effect of tirzepatide vs placebo on body weight. by Fei Lin (156666)

    Published 2023
    “…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
  20. 18060

    The results of safety in meta-analysis. by Fei Lin (156666)

    Published 2023
    “…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”